Guru Ownership Trend
Guru Analysis for Sarepta Therapeutics, Inc. (SRPT)
Sarepta Therapeutics, Inc. (SRPT), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $149.84 M.
Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $17.27 M net outflow during the quarter.
Recent activity highlights HOTCHKIS & WILEY who opened a new position. Conversely, Joel Greenblatt reduced exposure by 78.6%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Sarepta Therapeutics, Inc. (SRPT)
Major holders include Cliff Asness ($138.63 M), Renaissance Technologies (RenTech) ($36.23 M), HOTCHKIS & WILEY ($12.19 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 8.92 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $17.27 M, with 3 managers increasing positions and 5 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 2 fully exited SRPT. The total reported sell value was $42.18 M.
Yes, 2 managers opened new positions in SRPT, and 1 increased their existing holdings. The total reported buy value was $24.91 M.
